Topic: Luvox
Shares of Jazz Pharmaceuticals, Inc. (JAZZ) hit a new all-time high on Monday. The stock traded as high as $48.79 during mid-day trading and last...
2,217,667 shares of Jazz Pharmaceuticals, Inc. (JAZZ) traded hands on Friday, a 241.18% increase in volume compared to its 20-day average. The...
Equities research analysts at Barclays Capital (NYSE: BCS) initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) in a research note...
Jazz Pharmaceuticals (NASDAQ: JAZZ) was downgraded by equities research analysts at WBB Securities from a "buy" rating to a "hold" rating in a...
Jazz Pharmaceuticals (NASDAQ: JAZZ) was downgraded by equities research analysts at Zacks Investment Research from an "outperform" rating to a...
Big pharmaceutical companies are reinventing themselves as nimble players, targeting the pricing power and higher margins associated with niche...
An investment in a biotechnology company can offer the greatest of rewards or the ultimate feeling of defeat. A small investment into a clinical...
Obsessive-compulsive disorder, or OCD, is a disease usually characterized by anxiety and intrusive thoughts (obsessions) making the person repeat...
By Vanderson . Luminex Corporation (LMNX) announced Wednesday that it has launched its first pharmacogenomics test. The test, called the xTAG...
There are a number of medications that have been proven effective in the treatment of obsessive-compulsive disorder. They are called Selective Serotonin Reuptake Inhibitors (SSRI's) because they slow the reuptake of serotonin by the neurons. They include such drugs as fluvoxamine ...